Related Experiment Videos
Recent advances in the non-surgical management of atrial fibrillation
1Department of Cardiology, Guy's Hospital, London, UK.
Insights
Atrial fibrillation (AF) management involves restoring sinus rhythm, but recurrences are common. Radiofrequency ablation offers a safe, effective alternative to drug therapy for AF patients, improving outcomes.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia linked to substantial morbidity and mortality.
- Maintaining sinus rhythm is the primary treatment goal, yet drug therapies often fail, leading to common AF recurrence post-cardioversion.
- Antiarrhythmic drugs carry risks, including negative inotropic and proarrhythmic effects.
Purpose of the Study:
- To review current and emerging therapeutic strategies for managing atrial fibrillation.
- To highlight the efficacy and safety of interventional procedures compared to traditional drug therapy.
Main Methods:
- Review of existing literature on antiarrhythmic drugs, radiofrequency ablation, atrial pacing, and defibrillation for atrial fibrillation.
- Analysis of treatment outcomes, including rhythm maintenance, adverse effects, and palliative/curative potential.
Main Results:
- Radiofrequency ablation of the AV junction is a safe and effective palliative option for drug-refractory AF, enabling rate control without permanent pacing.
- Catheter ablation is being investigated as a potentially curative approach for AF.
- Atrial pacing may decrease AF incidence in specific patient groups.
- Low-energy intracardiac atrial defibrillation is feasible in humans.
Conclusions:
- Interventional strategies like radiofrequency ablation provide effective alternatives for AF management, particularly when drug therapy fails.
- Further research into catheter ablation and atrial defibrillation holds promise for more definitive AF treatments.
Abstract:
Atrial fibrillation is the commonest clinical arrhythmia, and is associated with significant morbidity and mortality. The treatment of choice is to restore and maintain sinus rhythm. Although certain antiarrhythmic drugs are more effective than placebo in maintaining sinus rhythm, recurrence of atrial fibrillation post cardioversion remains common. The use of antiarrhythmic drugs can be associated with serious adverse effects due to their negative inotropic and proarrhythmic effects. Radiofrequency ablation of the AV junction is a safe and effective palliative treatment option in patients who have failed drug therapy. Ventricular rate control without the need for permanent pacing can be achieved by AV nodal modification using radiofrequency energy. There is also interest in the role of catheter ablation as a possible curative procedure for atrial fibrillation. Atrial pacing can reduce the incidence of atrial fibrillation in certain subgroups of patients. Finally, low energy intracardiac atrial defibrillation has been shown to be feasible in humans.